Bioventus Inc. (NASDAQ: BVS) stock closed at 2.98 per share at the end of the most recent trading day (a -6.29% change compared to the prior day closing price) with a volume of 127.77K shares and market capitalization of 242.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 680 people. Bioventus Inc. CEO is Kenneth M. Reali.

The one-year performance of Bioventus Inc. stock is -57.12%, while year-to-date (YTD) performance is 14.18%. BVS stock has a five-year performance of %. Its 52-week range is between 0.7999 and 8.29, which gives BVS stock a 52-week price range ratio of 30.44%

Bioventus Inc. currently has a PE ratio of -1.90, a price-to-book (PB) ratio of 0.67, a price-to-sale (PS) ratio of 0.43, a price to cashflow ratio of 28.30, a PEG ratio of -, a ROA of -12.39%, a ROC of -21.48% and a ROE of -51.28%. The company’s profit margin is -43.63%, its EBITDA margin is -29.30%, and its revenue ttm is $386.28 Million , which makes it $6.24 revenue per share.

Of the last four earnings reports from Bioventus Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.06 for the next earnings report. Bioventus Inc.’s next earnings report date is 20th Nov 2023.

The consensus rating of Wall Street analysts for Bioventus Inc. is Hold (3), with a target price of $7, which is +127.27% compared to the current price. The earnings rating for Bioventus Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bioventus Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bioventus Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 62.76, ATR14 : 0.22, CCI20 : -43.83, Chaikin Money Flow : -0.09, MACD : -0.13, Money Flow Index : 38.04, ROC : -2.30, RSI : 42.02, STOCH (14,3) : 30.00, STOCH RSI : 0.32, UO : 50.57, Williams %R : -70.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bioventus Inc. in the last 12-months were: Anthony D¿Adamio (Option Excercise at a value of $0), Anthony D¿Adamio (Sold 3 409 shares of value $4 737 ), Bartholdson John A. (Buy at a value of $1 338 165), Bartholdson John A. (Option Exercise at a value of $0), Beyer Pat (Option Exercise at a value of $0), D'Adamio Anthony (Sold 0 shares of value $0 ), D'Adamio Anthony (Sold 3 409 shares of value $4 739 ), Guido J. Neels (Option Excercise at a value of $0), Hawkins William (Buy at a value of $235 400), Hawkins William (Option Excercise at a value of $0), HAWKINS WILLIAM A (Option Exercise at a value of $0), Katrina Church (Option Excercise at a value of $0), Katrina Church (Sold 1 449 shares of value $1 975 ), Katrina J. Church (Option Excercise at a value of $0), Katrina J. Church (Sold 1 843 shares of value $3 092 ), Kenneth M. Reali (Option Excercise at a value of $0), Kenneth M. Reali (Sold 9 811 shares of value $13 625 ), Ladone Mary (Option Excercise at a value of $0), Ladone Mary Kay (Option Exercise at a value of $0), Mark Leonard Singleton (Sold 0 shares of value $0 ), Mark Leonard Singleton (Sold 6 044 shares of value $7 676 ), McMurry-Heath Michelle (Option Exercise at a value of $0), Michelle Mcmurry-Heath (Option Excercise at a value of $0), NEELS GUIDO J (Option Exercise at a value of $0), Nohra Guy (Option Excercise at a value of $0), NOHRA GUY P (Option Exercise at a value of $0), Pat Beyer (Option Excercise at a value of $0), Reali Kenneth (Sold 0 shares of value $0 ), Reali Kenneth (Sold 9 811 shares of value $13 637 ), Stalnecker Susan (Option Excercise at a value of $0), STALNECKER SUSAN M (Option Exercise at a value of $0), Sutter Martin (Option Excercise at a value of $0), SUTTER MARTIN P (Option Exercise at a value of $0), William A. Hawkins (Option Excercise at a value of $0)